2023 Division Of Research Annual Report

42 DMITRIY MINOND, PH.D. Scientist, NSU Rumbaugh-Goodwin Institute for Cancer Research, and Associate Professor NSU Barry and Judy Silverman College of Pharmacy NSU Rumbaugh-Goodwin Institute for Cancer Research PATENTS/AVAILABLE TECHNOLOGIES f) Therapeutics: method for treating rheumatoid arthritis (Provisional patent application submitted March 8, 2022.) g) Therapeutics: SiRNA for treating metastatic melanoma (PCT application published June 21, 2018.) f) g) HIGHLIGHTED GRANT $573,000 | Florida Department of Health: Bankhead-Coley Cancer Research Program Discovery Science | Spliceosomal modulation for regulation of Melanoma Immunogenicity LISA ROBISON, PH.D. Associate Professor NSU College of Psychology HIGHLIGHTED GRANT $154,000 | American Heart Association | Targeting the Renin-Angiotensin System to Ameliorate Cerebral Amyloid Angiopathy Robert Speth, Ph.D. NSU Barry and Judy Silverman College of Pharmacy GRANT COLLABORATOR HUMAN DISEASE: THE FRONT LINE

RkJQdWJsaXNoZXIy NDE4MDg=